Medical Radiation Detection Market Size, Growth, Trends | Report 2023-2032
The global medical radiation detection market was surpassed at USD 944.54 million in 2022 and is expected to hit around USD 1,955.80 million by 2032, growing at a CAGR of 7.55% from 2023 to 2032.
Key Pointers
Report Scope of the Medical Radiation Detection Market
| Report Coverage | Details |
| Market Size in 2022 | USD 944.54 million |
| Revenue Forecast by 2032 | USD 1,955.80 million |
| Growth rate from 2023 to 2032 | CAGR of 7.55% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Thermo Fisher Scientific, Inc.; UAB Polimaster Europe; PTW Freiburg GmbH; ATOMTEX; Sanlar imex services private limited; LANDAUER;Mirion Technologies, Inc; MP BIOMEDICALS.; SIERRA RADIATION DOSIMETRY SERVICE, INC.; IBA Dosimetry GmbH |
The primary factor driving the industry is due to greater demand for radiation detection and medical diagnostics.
As per the estimates CDC in 2020 cancer was the second leading cause of death in the U.S. The increase in the prevalence of this disease is fuelling the demand for the treatment which in turn, is influencing the demand for detection devices. Additionally advancements in technology such as the use of artificial intelligence and nanotechnology aid in detecting the very low level of radiation with high accuracy further influencing the growth of the market.
The COVID-19 pandemic has had a significant impact on the medical radiation detection, monitoring and safety market. Radiation therapy is a critical component of cancer treatment, and the pandemic has disrupted cancer diagnosis and treatment globally. Many cancer patients have been forced to postpone or cancel their radiation therapy treatments due to the pandemic's limitations on healthcare systems and resources. The pandemic has also resulted in a decline in the number of cancer diagnoses, which has led to a decrease in the demand for radiation therapy. Furthermore, the COVID-19 outbreak had disrupted global supply chains and caused delays in the delivery of radiation therapy equipment and supplies. However, the market has also accelerated the adoption of advanced technologies in radiation therapy, such as image-guided radiation therapy and proton therapy, which can improve treatment outcomes and reduce the risk of side effects. These advancements are expected to drive the growth of the medical radiation therapy market over the forecast period.
Type Insights
On the basis of type, the market is further segmented into gas-filled detectors, scintillators, and solid-state. Gas-filled detectors accounted for the highest revenue share in 2022 owning popularity due to several advantages they offer over other types of radiation detectors. For instance, gas-filled detectors are highly sensitive to ionizing radiation and can detect very low levels of radiation, making them ideal for use in environments where radiation levels need to be monitored carefully. Additionally, gas-filled detectors are able to detect a wide range of radiation types, including alpha particles, beta particles, gamma rays, and X-rays, which makes them versatile and suitable for use in a variety of applications. Solid-state detectors is expected to grow at the fastest CAGR over the forecast period. Solid-state detectors are highly efficient at detecting ionizing radiation, they can convert a large proportion of incident radiation into an electrical signal. This allows them to detect very low levels of radiation with high accuracy. For example, according to the U.S. Nuclear Regulatory Commission, solid-state detectors are more efficient than gas-filled detectors for detecting low-energy gamma rays.
Product Insights
On the basis of product, the market is further segmented into personal dosimeters, area process dosimeters, surface contamination monitors, and others. Personal dosimeters accounted for the highest revenue share in 2022 owning to its properties such as being lightweight, and easy to access. Personal dosimeters are used to monitor the amount of radiation exposure that workers receive in environments where radiation exposure is a risk. This is particularly important in industries such as nuclear power, medical imaging, and radiography, where workers are exposed to ionizing radiation. It ensures that workers are not exposed to dangerous levels of radiation, protecting their health and safety. Area process dosimeters provide real-time monitoring of radiation levels, allowing operators to make adjustments to the process as needed. This helps to prevent overexposure to radiation and ensures that the process is functioning optimally.
End-use Insights
On the basis of end-use the market is segmented into hospitals, ambulatory surgical centers diagnostic imaging centers, and home care. The hospitals segment accounted for the highest revenue share in 2022. This is attributed to the increasing geriatric population and an increase in chronic diseases, there is a growing demand for medical imaging procedures, such as X-rays, CT scans, and PET scans. As per the estimates of the United Nation in 2019 approximately 703 million people globally were more than 65 years aforementioned factor is driving the market. Medical radiation detectors are essential in these procedures to ensure that patients receive the correct amount of radiation and to prevent overexposure.
The diagnostic imaging centers are expected to grow at the fastest CAGR over the forecast period owing to the medical radiation advancements in technology, manufacturers are making detectors more accurate, reliable, and user-friendly. For instance, some detectors now use solid-state detectors, which offer higher efficiency and sensitivity than gas-filled detectors.
Regional Insights
North America dominated the global market and accounted for a revenue share of 34.23% in 2022 this is attributed to growing concern about the potential risks associated with exposure to ionizing radiation in medical procedures. As a result, medical facilities and regulatory bodies are placing more emphasis on radiation safety. This has led to an increase in demand for medical radiation detectors that can accurately measure radiation levels and help ensure patient safety.
Additionally, the governments in North America have implemented strict regulations on the use of radiation in medical procedures. This has led to an increase in demand for medical radiation detectors that can ensure compliance with these regulations.
The Asia Pacific region is expected to grow at the fastest CAGR of 7.99% owing to an increase in chronic diseases such as cancer. Many cancer treatments, such as radiation therapy, use ionizing radiation. As the incidence of cancer continues to rise, the demand for medical radiation detectors is also increasing to help ensure that patients receive safe and effective treatment. As per the estimates of NIH in 2020 Asian region witnessed 49.3 of global cancer incidences.
Medical Radiation Detection Market Segmentations:
By Type
By Product
By End-use
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Type Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Medical Radiation Detection Market
5.1. COVID-19 Landscape: Medical Radiation Detection Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Medical Radiation Detection Market, By Type
8.1. Medical Radiation Detection Market, by Type, 2023-2032
8.1.1 Gas-filled Detectors
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Scintillators
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Solid-state
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Medical Radiation Detection Market, By Product
9.1. Medical Radiation Detection Market, by Product, 2023-2032
9.1.1. Personal Dosimeters
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Area Process Dosimeters
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Surface Contamination Monitors
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Medical Radiation Detection Market, By End-use
10.1. Medical Radiation Detection Market, by End-use, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Ambulatory Surgical Centers
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Diagnostic Imaging Centers
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Homecare
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Medical Radiation Detection Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2020-2032)
11.1.2. Market Revenue and Forecast, by Product (2020-2032)
11.1.3. Market Revenue and Forecast, by End-use (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Product (2020-2032)
11.1.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Product (2020-2032)
11.1.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2020-2032)
11.2.2. Market Revenue and Forecast, by Product (2020-2032)
11.2.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Product (2020-2032)
11.2.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Product (2020-2032)
11.2.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Product (2020-2032)
11.2.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Product (2020-2032)
11.2.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2020-2032)
11.3.2. Market Revenue and Forecast, by Product (2020-2032)
11.3.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Product (2020-2032)
11.3.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Product (2020-2032)
11.3.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Product (2020-2032)
11.3.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Product (2020-2032)
11.3.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.4.2. Market Revenue and Forecast, by Product (2020-2032)
11.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Product (2020-2032)
11.4.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Product (2020-2032)
11.4.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Product (2020-2032)
11.4.6.3. Market Revenue and Forecast, by End-use (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Product (2020-2032)
11.4.7.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.5.2. Market Revenue and Forecast, by Product (2020-2032)
11.5.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Product (2020-2032)
11.5.4.3. Market Revenue and Forecast, by End-use (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Product (2020-2032)
11.5.5.3. Market Revenue and Forecast, by End-use (2020-2032)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. UAB Polimaster Europe
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. PTW Freiburg GmbH
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. ATOMTEX
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Sanlar imex services private limited
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. LANDAUER
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Mirion Technologies, Inc
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. MP BIOMEDICALS.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. SIERRA RADIATION DOSIMETRY SERVICE, INC.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. IBA Dosimetry GmbH
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers